Skip to content

Quality and outcomes in global cancer surgery.

Quality and outcomes in global cancer surgery: a prospective, international cohort study - GS3

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/11/016251
Enrollment
5000
Registered
2018-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K319- Disease of stomach and duodenum, unspecified

Interventions

None listed

Sponsors

Tata memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive patients undergoing therapeutic surgery curative or palliative for breast gastric and colorectal cancer should be included Surgery is defined as a procedure requiring a skin incision performed under general or neuraxial eg regional epidural or spinal anaesthesia Both elective and emergency procedures should be included Include patients in whom the pre operative diagnosis was thought to be benign but was subsequently found to be cancer eg bowel obstruction found to be due to cancer during surgery Include patients in whom the pre-�­operative diagnosis was thought to be cancer but was subsequently found to be benign disease ensure the pathology variable indicates not cancer will not be included in primary analysis Laparoscopic laparoscopic converted robotic and open cases should be included Patients aged 18 years and over should be included Surgery may be with curative or palliative intent Include patients in whom curative surgery was attempted but abandoned eg open close laparotomy

Exclusion criteria

Exclusion criteria: Operations where breast gastric or colorectal cancer is not suspected to be the primary pathology should be excluded Patients undergoing a procedure purely for diagnosis or staging should be excluded eg open breast biopsy staging laparoscopy Patients undergoing a procedure which does not require a skin incision should be excluded eg colonoscopy endoscopy alone chemo radiotherapy alone Patients with recurrence of breast colorectal or gastric cancer should be excluded

Design outcomes

Primary

MeasureTime frame
Mortality and complication rates after cancer surgery.Timepoint: 30 days

Secondary

MeasureTime frame
Cancer-�­specific quality measuresTimepoint: 30 days

Countries

India, United Kingdom

Contacts

Public ContactDr C S Pramesh

Tata Memorial Hospital Parel Mumbai

prameshcs@tmc.gov.in02224176310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026